Opendata, web and dolomites

Rhizomia SIGNED

A novel cost-efficient hydroponic technology to grow high value plant roots for nutraceuticals, pharmaceuticals & cosmetics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Rhizomia" data sheet

The following table provides information about the project.

Coordinator
BOTALYS 

Organization address
address: QUAI DES USINES 8
city: ATH
postcode: 7800
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 3˙150˙000 €
 EC max contribution 2˙205˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BOTALYS BE (ATH) coordinator 2˙205˙000.00

Map

 Project objective

Out of 391,000 plants known to science only 31,000 have practical applications. 18,000 are classified as medicinal plants, which means they have a documented medicinal effect. But only 150 plants are cultivated industrially. Medicinal plants are a huge global market, conservatively estimated at €70bn in 2015. Plant roots provide many of the important biologically active ingredients found in nutraceuticals, pharmaceuticals, cosmetics, food additives & other products. Production of such active ingredients from plants (cultivated by horticultural means or harvested in the wild) is not sufficient to meet the growing market demand. New sustainable production methods revolve around in-vitro cultivation in bioreactors. The main limiting factor of the current solutions is the plant biomass growth rate. Existing bioreactors are unable to produce sufficient amounts of biomass & active ingredients at economically attractive speeds, limiting their use. Rhizomia from Botalys is a novel technology that enables a 2x faster biomass growth (reaching doubling time of 6-8 days for ginseng roots) and a 2-3x boost in active ingredient elicitation level (10-12% concentration of the top 7 ginsenosides instead of 4% concentration of the top 7 ginsenosides in harvested wild ginseng). There is an annual market of ~80,000 tons of dry ginseng matter, growing at ~8% per year. It is dominated by non-European producers. With Rhizomia we are able to produce best-in-class red (post-processed) ginseng with unmatched profile of ginsenosides—active ingredients. With Rhizomia-produced ginseng we are aiming to take 30-35% market share already by 2030 by building a large-scale production facility and putting EU back on the map of major ginseng exporters.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "RHIZOMIA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "RHIZOMIA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

SMART UV (2019)

Intelligent Ultraviolet (UV) Radiation Filters

Read More  

BEMYEYES (2019)

Specialized Help from Be My Eyes – harnessing technology to connect companies directly with their blind and visually impaired users

Read More  

PD-Watch (2019)

Wearable technology for the selective detection and continuous monitoring of movement disorders related to Parkinson’s disease

Read More